ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $445 | +290.4% | 350 | 0.0% | 0.00% | – |
Q2 2023 | $114 | -24.5% | 350 | 0.0% | 0.00% | – |
Q1 2023 | $151 | -18.8% | 350 | 0.0% | 0.00% | – |
Q4 2022 | $186 | – | 350 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -99.9% | 350 | 0.0% | 0.00% | – |
Q1 2021 | $1,628,000 | +162700.0% | 350 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 350 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $3,000 | -40.0% | 350 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $5,000 | +150.0% | 350 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $2,000 | – | 350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ground Swell Capital, LLC | 25,445 | $19,000 | 0.05% |
ETF MANAGERS GROUP, LLC | 2,258,970 | $1,654,000 | 0.05% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 116,780 | $85,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 131,036 | $96,000 | 0.01% |
Bernardo Wealth Planning LLC | 30,469 | $20,000 | 0.01% |
PCG Wealth Advisors, LLC | 15,200 | $12,000 | 0.00% |
Penserra Capital Management LLC | 212,298 | $155,000 | 0.00% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $36,000 | 0.00% |
King Wealth Management Group | 16,000 | $12,000 | 0.00% |
Vident Investment Advisory, LLC | 105,398 | $77,000 | 0.00% |